China Biologic Starts Selling Human Immunoglobulin To Neighboring India, Scans Globe For New Markets
This article was originally published in PharmAsia News
Executive Summary
BEIJING - China Biologic Products has signed a unique deal to supply India with plasma-based biopharmaceuticals, and is scanning the global market for other potential importers, according to company executives